Profile
Full Name
Zenas BioPharma, Inc.Ticker Symbol
ZBIOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
September 13, 2024Indexes
Not includedWebsite
http://zenasbio.comEmployees
130Key Details
Price
$9.23(-12.59%)
Market cap
$386.13M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$5.00M(-90.00% YoY)
Annual EPS
-$11.89(-457.80% YoY)
PE ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Zenas BioPharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
May 16, 25 HC Wainwright & Co.
BuyMar 20, 25 Wedbush
OutperformMar 12, 25 HC Wainwright & Co.
BuyMar 12, 25 Guggenheim
BuyFeb 4, 25 Wolfe Research
OutperformDec 16, 24 HC Wainwright & Co.
BuyDec 11, 24 Morgan Stanley
OverweightDec 3, 24 Guggenheim
BuyInstitutional Ownership
- What is the ticker symbol for Zenas BioPharma?
- Does Zenas BioPharma pay dividends?
- What sector is Zenas BioPharma in?
- What industry is Zenas BioPharma in?
- What country is Zenas BioPharma based in?
- When did Zenas BioPharma go public?
- Is Zenas BioPharma in the S&P 500?
- Is Zenas BioPharma in the NASDAQ 100?
- Is Zenas BioPharma in the Dow Jones?
- When was Zenas BioPharma's last earnings report?
- When does Zenas BioPharma report earnings?
- Should I buy Zenas BioPharma stock now?
What is the ticker symbol for Zenas BioPharma?
The ticker symbol for Zenas BioPharma is NASDAQ:ZBIO
Does Zenas BioPharma pay dividends?
No, Zenas BioPharma does not pay dividends
What sector is Zenas BioPharma in?
Zenas BioPharma is in the Healthcare sector
What industry is Zenas BioPharma in?
Zenas BioPharma is in the Biotechnology industry
What country is Zenas BioPharma based in?
Zenas BioPharma is headquartered in United States
When did Zenas BioPharma go public?
Zenas BioPharma's initial public offering (IPO) was on September 13, 2024
Is Zenas BioPharma in the S&P 500?
No, Zenas BioPharma is not included in the S&P 500 index
Is Zenas BioPharma in the NASDAQ 100?
No, Zenas BioPharma is not included in the NASDAQ 100 index
Is Zenas BioPharma in the Dow Jones?
No, Zenas BioPharma is not included in the Dow Jones index
When was Zenas BioPharma's last earnings report?
Zenas BioPharma's most recent earnings report was on Nov 12, 2024
When does Zenas BioPharma report earnings?
The next expected earnings date for Zenas BioPharma is May 30, 2025
Should I buy Zenas BioPharma stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions